Dr. Shivadasan Anoop
COO & Test Facility Management
- Email
- Website
-
Address InfoEdirne, Turkey
Over 16 years of experience
My expertise spans various scientific disciplines, including teaching, surgery, toxicology, breeding, immunology, regenerative medicine, pathology, and physiology. During my veterinary internship and professional career, I have held positions such as attending veterinarian, study director, manager, research assistant, and department head, and have contributed to specialized areas such as surgical procedures, sample collection, drug administration, breeding, treatment, behavioral assessment, safety pharmacology (telemetry), euthanasia, necropsy, and animal welfare. My experience encompasses a wide range of animal species, including dogs, rabbits, guinea pigs, cats, rats, mice, ferrets, Japanese quails, pigeons, zebrafish, goats, sheep, pigs, mini-pigs, cattle, and non-human primates.
Professional Profile
- Expert in laboratory animal science, attending veterinarian, toxicologist, and experienced surgeon
- Establishment of the first commercial, CCSEA-approved beagle breeding facility in India (Isoquimen India / Palamur Biosciences Pvt. Ltd.)
- Initiated and established the preclinical and non-clinical platform for the non-rodent division of pharmacokinetic and toxicokinetic studies at Palamur Biosciences Pvt. Ltd., including various species such as dogs, mini-pigs, pigs, non-human primates, and cattle
- Established the Safety Pharmacology – Telemetry department at Palamur Biosciences Pvt. Ltd.
- One of the key contributors to the establishment of the Medical Device Testing and Training Division at Palamur Biosciences, founded under the auspices of the National Biopharma Mission (NBM) and BIRAC
- Preclinical and regulatory toxicology expertise across multiple sectors (pharmaceuticals, chemicals, medical devices, food safety, environmental toxicology)
- Experience in non-clinical study design and management, including in vivo and in vitro studies
- Toxicological risk assessments (e.g., PDE-OEL, leachables/extractables, genotoxicity, impurities, ecotoxicology)
- Expertise in drug development (IND, NDA, ANDA – 505(j), 505(b)2 applications)
- Regulatory experience with global authorities (USFDA, EMA, CDSCO, ANVISA, CFDA, TGA, MFDS, etc.)
- Leadership skills (management of CRO collaborations, regulatory responses, oversight of preclinical studies)